Optimizing heparin compounds: a working construct for future antithrombotic drug development.
Publication
, Journal Article
Becker, RC
Published in: J Thromb Thrombolysis
August 2004
Duke Scholars
Published In
J Thromb Thrombolysis
DOI
ISSN
0929-5305
Publication Date
August 2004
Volume
18
Issue
1
Start / End Page
55 / 58
Location
Netherlands
Related Subject Headings
- Humans
- Heparin
- Fibrinolytic Agents
- Drug Design
- Cardiovascular System & Hematology
- Animals
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C. (2004). Optimizing heparin compounds: a working construct for future antithrombotic drug development. J Thromb Thrombolysis, 18(1), 55–58. https://doi.org/10.1007/s11239-004-0176-x
Becker, Richard C. “Optimizing heparin compounds: a working construct for future antithrombotic drug development.” J Thromb Thrombolysis 18, no. 1 (August 2004): 55–58. https://doi.org/10.1007/s11239-004-0176-x.
Becker RC. Optimizing heparin compounds: a working construct for future antithrombotic drug development. J Thromb Thrombolysis. 2004 Aug;18(1):55–8.
Becker, Richard C. “Optimizing heparin compounds: a working construct for future antithrombotic drug development.” J Thromb Thrombolysis, vol. 18, no. 1, Aug. 2004, pp. 55–58. Pubmed, doi:10.1007/s11239-004-0176-x.
Becker RC. Optimizing heparin compounds: a working construct for future antithrombotic drug development. J Thromb Thrombolysis. 2004 Aug;18(1):55–58.
Published In
J Thromb Thrombolysis
DOI
ISSN
0929-5305
Publication Date
August 2004
Volume
18
Issue
1
Start / End Page
55 / 58
Location
Netherlands
Related Subject Headings
- Humans
- Heparin
- Fibrinolytic Agents
- Drug Design
- Cardiovascular System & Hematology
- Animals
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences